Detection of subclinical tubular injury after renal transplantation:: Comparison of urine protein analysis with allograft histopathology

被引:71
作者
Schaub, Stefan
Mayr, Michael
Hoenger, Gideon
Bestland, Jennifer
Steiger, Juerg
Regeniter, Axel
Mihatsch, Michael J.
Wilkins, John A.
Rush, David
Nickerson, Peter
机构
[1] Univ Basel Hosp, Clin Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland
[2] Univ Manitoba, Fac Med, Manitoba Ctr Proteom & Syst Biol, Sect Biomed Proteom & Rheumatol, Winnipeg, MB R3T 2N2, Canada
[3] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland
[4] Univ Manitoba, Fac Biol, Manitoba Ctr Proteom & Syst Biol, Sect Nephrol & Biomed Proteom, Winnipeg, MB R3T 2N2, Canada
关键词
renal allograft rejection; tubular injury; urine proteins; protocol biopsy; noninvasive monitoring;
D O I
10.1097/01.tp.0000268808.39401.e8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Tubulointerstitial injury due to rejection leads to tubular atrophy (TA)/interstitial fibrosis (IF) followed by deterioration of allograft function. This study investigated whether urinary tubular injury biomarkers can detect subclinical tubulitis found in protocol biopsies allowing for a noninvasive screening procedure. Methods. Four rigidly defined groups (stable transplants with normal tubular histology [n = 24], stable transplants with subclinical tubulitis [n = 38], patients with clinical tubulitis Ia/Ib [n = 18), and patients with other clinical tubular pathologies [n = 20]) were compared for differences in urinary intact/cleaved beta 2-microglobulin (i/c beta 2m), retinol-binding protein (RBP), neutrophil-gelatinase-associated lipocalin (NGAL), and alpha 1-microglobulin (alpha 1m). Results. Tubular proteinuria was present in 38% (RBP) to 79% (alpha 1m) of patients in the stable transplant with normal tubular histology group. The stable transplant with subclinical tubulitis group had slightly higher levels of i/c beta 2m (P=0.11), RBP (P=0.17), alpha 1m (P=0.09), and NGAL (P=0.06) than the stable transplant with normal tubular histology group with a substantial overlap. The clinical tubulitis Ia/Ib and the other clinical tubular pathology groups had significantly higher levels of RBP, NGAL, and alm than stable transplants with normal tubular histology or stable transplants with subclinical tubulitis (P<0.002). Conclusions. None of the investigated biomarkers allow for clear differentiation between stable transplants with normal tubular histology and stable transplants with subdinical tubulitis. Therefore, the protocol allograft biopsy currently remains the preferred tool to screen for subclinical tubulitis. Further longitudinal studies should determine whether tubular proteinuria in stable transplants with normal tubular histology indicates a clear risk for early development of TA/IF.
引用
收藏
页码:104 / 112
页数:9
相关论文
共 41 条
[1]   Time course of proteinuria after living-donor kidney transplantation [J].
Artz, MA ;
Dooper, PMM ;
Meuleman, EJH ;
van der Vliet, JA ;
Wetzels, JFM .
TRANSPLANTATION, 2003, 76 (02) :421-423
[2]   STABILITY OF BETA-2-MICROGLOBULIN AND RETINOL BINDING-PROTEIN AT DIFFERENT VALUES OF PH AND TEMPERATURE IN NORMAL AND PATHOLOGICAL URINE [J].
BLUMSOHN, A ;
MORRIS, BW ;
GRIFFITHS, H ;
RAMSEY, CF .
CLINICA CHIMICA ACTA, 1991, 195 (03) :133-138
[3]   Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival [J].
Câmara, NOS ;
Silva, MS ;
Nishida, S ;
Pereira, AB ;
Pacheco-Silva, A .
TRANSPLANTATION, 2004, 78 (02) :269-275
[4]   Kidney allograft fibrosis and atrophy early after living donor transplantation [J].
Cosio, FG ;
Grande, JP ;
Larson, TS ;
Gloor, JM ;
Velosa, JA ;
Textor, SC ;
Griffin, MD ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (05) :1130-1136
[5]   Predicting subsequent decline in kidney allograft function from early surveillance biopsies [J].
Cosio, FG ;
Grande, JP ;
Wadei, H ;
Larson, TS ;
Griffin, MD ;
Stegall, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) :2464-2472
[6]   Subclinical rejection in tacrolimus-treated renal transplant recipients [J].
Gloor, JM ;
Cohen, AJ ;
Lager, DJ ;
Grande, JP ;
Fidler, ME ;
Velosa, JA ;
Larson, TS ;
Schwab, TR ;
Griffin, MD ;
Prieto, M ;
Nyberg, SL ;
Sterioff, S ;
Kremers, WK ;
Stegall, MD .
TRANSPLANTATION, 2002, 73 (12) :1965-1968
[7]   Computerized image analysis of sirius red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function [J].
Grimm, PC ;
Nickerson, P ;
Gough, J ;
McKenna, R ;
Stern, E ;
Jeffery, J ;
Rush, DN .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06) :1662-1668
[8]   Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis [J].
Herget-Rosenthal, S ;
Poppen, D ;
Hüsing, J ;
Marggraf, G ;
Pietruck, F ;
Jakob, HG ;
Philipp, T ;
Kribben, A .
CLINICAL CHEMISTRY, 2004, 50 (03) :552-558
[9]   Risk factors for early epithelial to mesenchymal transition in renal grafts [J].
Hertig, A. ;
Verine, J. ;
Mougenot, B. ;
Jouanneau, C. ;
Ouali, N. ;
Sebe, P. ;
Glotz, D. ;
Ancel, P. -Y. ;
Rondeau, E. ;
Xu-Dubois, Y. -C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :2937-2946
[10]   Discovery of protein biomarkers for renal diseases [J].
Hewitt, SM ;
Dear, J ;
Star, RA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (07) :1677-1689